Liraglutide Suppresses Myocardial Fibrosis Progression by Inhibiting the Smad Signaling Pathway
Crossref DOI link: https://doi.org/10.1007/s11596-023-2776-8
Published Online: 2023-08-18
Published Print: 2023-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Wen
Mi, Hong
He, De-ying
Li, Wen
Songyang, Yi-yan
Text and Data Mining valid from 2023-08-18
Version of Record valid from 2023-08-18
Article History
Received: 5 April 2023
Accepted: 11 May 2023
First Online: 18 August 2023
Conflict of Interest Statement
: The authors declare that they have no conflicts of interest.